Business Segments Novo Nordisk A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 06:20:49 11/05/2026 pm IST			5-day change	1st Jan Change
299.20 ^DKK	+3.07%		+5.96%	-7.82%

06:13pm	Novo Nordisk Agrees Divestment of Parkinson's Disease Cell Therapy Program to Cellular Intelligence	MT
06:12pm	Zuckerberg backed-Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy	RE

Breakdown by Business Segment (DKK)

Fiscal Period: December	2021	2022	2023	2024	2025
Pharmaceutical Products
Diabetes and Obesity Care	12TCr	16TCr	22TCr	27TCr	29TCr
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	489.5Cr	570.1Cr	819.5Cr	710.4Cr	1.31TCr
Operating Income	4.95TCr	6.74TCr	9.96TCr	13TCr	13TCr
Rare Disease	1.92TCr	2.05TCr	1.72TCr	1.86TCr	1.96TCr
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
D&A	113Cr	166.1Cr	121.8Cr	144.1Cr	160.3Cr
Operating Income	910.6Cr	741.4Cr	295.1Cr	62Cr	121.2Cr
Total Assets	-	-	-	-	-

Geographical breakdown of sales (DKK)

Fiscal Period: December	2021	2022	2023	2024	2025
United States of America (USA)	6.3TCr	8.47TCr	13TCr	17TCr	17TCr
Total Assets	-	-	-	5.71TCr	7.74TCr
CAPEX	-	-	-	-	-
Total Assets	-	-	-	18TCr	19TCr
Europe and Canada	-	-	-	-	6.61TCr
Emerging Markets	-	-	-	-	3.04TCr
APAC	-	-	-	-	2.07TCr
Region China	1.6TCr	1.62TCr	1.67TCr	1.85TCr	1.87TCr
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EMEA	3.77TCr	4.42TCr	5.09TCr	6.04TCr	-
North America (Excl. US)	425.4Cr	645.1Cr	909.5Cr	1.08TCr	-
Total Assets	-	-	-	-	-
Africa, Asia, Middle East and Oceania (AAMEO)	-	-	-	-	-
Total Assets	-	-	-	-	-
Latin America	-	-	-	-	-
Total Assets	-	-	-	-	-
Pacific	-	-	-	-	-
Total Assets	-	-	-	-	-
Japan & Korea	-	-	-	-	-
Total Assets	-	-	-	-	-
Europe	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
Rest of the World	1.98TCr	2.54TCr	2.81TCr	3.33TCr	-
International Operations	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-